ECTRIMS eLearning

Fatigue and related factors in persons with multiple sclerosis
Author(s): ,
Y. Yorgun
Affiliations:
Odemis State Hospital
,
A.T. Ozdogar
Affiliations:
Dokuz Eylul University, IZMIR
,
T. Aslan
Affiliations:
Dokuz Eylul University, IZMIR
,
C. Babayev
Affiliations:
Dokuz Eylul University, Izmir
,
O. Sagici
Affiliations:
Dokuz Eylul University, IZMIR
,
T. Kahraman
Affiliations:
Izmir Katip Celebi University, IZMIR, Turkey
,
S. Ozakbas
Affiliations:
Dokuz Eylul University, IZMIR
Multiple Sclerosis Research Group
Multiple Sclerosis Research Group
Affiliations:
ECTRIMS Learn. Babayev C. 10/10/18; 229224; EP1385
Cavid Babayev
Cavid Babayev
Contributions
Abstract

Abstract: EP1385

Type: Poster Sessions

Abstract Category: Clinical aspects of MS - MS symptoms

Fatigue is the most commonly reported symptom in multiple sclerosis (MS) and is observed in 53-97% of people with MS (pwMS). The presence of fatigue lowers the quality of life and pwMS generally regard fatigue as the most disturbing symptom. Disease duration, disability level, number of attacks, sleep quality and depression levels may be associated with fatigue in pwMS.
The aim was to compare the duration of disease, level of disability, number of attacks, sleep quality and depression levels in pwMS with or without fatigue.
In total, 373 pwMS enrolled in this study. The levels of disability, sleepiness and depression were assessed with the Extended Disability Status Scale (EDSS), the Epworth Sleepiness Scale, and the Beck Depression Scale, respectively. The level of fatigue was assessed with the Modified Fatigue Impact Scale (MFIS) and 38 points for fatigue were considered cut-off values.
The fatigue was detected in 242 participants (64.88%).Duration of disease, disability level, number of attacks, daytime somnolence and depression levels were significantly higher in participants with fatigue than participants without fatigue (p < 0.05).
This study has suggested that pwMS with fatigue have more disease duration, disability level, number of attacks, daytime sleepiness and depression levels than without fatigue. While the evaluation and rehabilitation programs for fatigue are being organized, the duration of illness, disability level, number of attacks, sleep quality and depression levels should also be considered.
Disclosure: Yuksel Yorgun: nothing to disclose
Asiye Tuba Ozdogar: nothing to disclose
Taha Aslan: nothing to disclose
Cavid Babayev: nothing to disclose
Ozge Sagici: nothing to disclose
Turhan Kahraman: nothing to disclose
Serkan Ozakbas: nothing to disclose

Abstract: EP1385

Type: Poster Sessions

Abstract Category: Clinical aspects of MS - MS symptoms

Fatigue is the most commonly reported symptom in multiple sclerosis (MS) and is observed in 53-97% of people with MS (pwMS). The presence of fatigue lowers the quality of life and pwMS generally regard fatigue as the most disturbing symptom. Disease duration, disability level, number of attacks, sleep quality and depression levels may be associated with fatigue in pwMS.
The aim was to compare the duration of disease, level of disability, number of attacks, sleep quality and depression levels in pwMS with or without fatigue.
In total, 373 pwMS enrolled in this study. The levels of disability, sleepiness and depression were assessed with the Extended Disability Status Scale (EDSS), the Epworth Sleepiness Scale, and the Beck Depression Scale, respectively. The level of fatigue was assessed with the Modified Fatigue Impact Scale (MFIS) and 38 points for fatigue were considered cut-off values.
The fatigue was detected in 242 participants (64.88%).Duration of disease, disability level, number of attacks, daytime somnolence and depression levels were significantly higher in participants with fatigue than participants without fatigue (p < 0.05).
This study has suggested that pwMS with fatigue have more disease duration, disability level, number of attacks, daytime sleepiness and depression levels than without fatigue. While the evaluation and rehabilitation programs for fatigue are being organized, the duration of illness, disability level, number of attacks, sleep quality and depression levels should also be considered.
Disclosure: Yuksel Yorgun: nothing to disclose
Asiye Tuba Ozdogar: nothing to disclose
Taha Aslan: nothing to disclose
Cavid Babayev: nothing to disclose
Ozge Sagici: nothing to disclose
Turhan Kahraman: nothing to disclose
Serkan Ozakbas: nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies